• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示耐碳青霉烯类肠杆菌科细菌共同定植的多样性

Unraveling the Diversity of Co-Colonization by CPE.

作者信息

Levi Gabrielle, Lurie-Weinberger Mor, Keren-Paz Alona, Andremont Antoine O, Schwartz David, Carmeli Yehuda

机构信息

National Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv 6423906, Israel.

Microbiology Department, Université Paris Diderot, Sorbonne Paris Cité, 75018 Paris, France.

出版信息

Microorganisms. 2022 Jun 25;10(7):1292. doi: 10.3390/microorganisms10071292.

DOI:10.3390/microorganisms10071292
PMID:35889010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9316973/
Abstract

Antibiotic-resistant bacteria, and more specifically, carbapenem-producing Enterobacterales (CPE) strains, are increasing worldwide. Despite their growing prevalence, in most high-income countries, the detection of CPE is still considered a low-frequency event. Sporadically, patients co-colonized with distinct CPE strains and/or different carbapenemase enzymes are detected. In this paper, we present three cases that illustrate the underlying mechanisms of co-colonization, focusing on horizontal gene transfer (HGT) and patient-to-patient transmission. We also demonstrate the diversity of CPE species and discuss the potential consequences of co-colonization.

摘要

耐抗生素细菌,更具体地说,产碳青霉烯类肠杆菌科(CPE)菌株在全球范围内不断增加。尽管其流行率不断上升,但在大多数高收入国家,CPE的检测仍被视为低频事件。偶尔会检测到同时携带不同CPE菌株和/或不同碳青霉烯酶的患者。在本文中,我们介绍了三个案例,阐述了共同定植的潜在机制,重点是水平基因转移(HGT)和患者间传播。我们还展示了CPE物种的多样性,并讨论了共同定植的潜在后果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b9/9316973/0cc33512068a/microorganisms-10-01292-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b9/9316973/977e736d173b/microorganisms-10-01292-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b9/9316973/5d790150a8cc/microorganisms-10-01292-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b9/9316973/0cc33512068a/microorganisms-10-01292-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b9/9316973/977e736d173b/microorganisms-10-01292-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b9/9316973/5d790150a8cc/microorganisms-10-01292-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b9/9316973/0cc33512068a/microorganisms-10-01292-g003.jpg

相似文献

1
Unraveling the Diversity of Co-Colonization by CPE.揭示耐碳青霉烯类肠杆菌科细菌共同定植的多样性
Microorganisms. 2022 Jun 25;10(7):1292. doi: 10.3390/microorganisms10071292.
2
Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.产碳青霉烯酶与非产碳青霉烯酶肠杆菌科细菌感染的危险因素:一项病例对照研究。
Clin Microbiol Infect. 2023 May;29(5):629-634. doi: 10.1016/j.cmi.2023.01.005. Epub 2023 Jan 12.
3
Intestinal co-colonization with different carbapenemase-producing isolates is not a rare event in an OXA-48 endemic area.在OXA-48流行地区,肠道被不同产碳青霉烯酶菌株共定植并非罕见事件。
EClinicalMedicine. 2019 Oct 17;15:72-79. doi: 10.1016/j.eclinm.2019.09.005. eCollection 2019 Oct.
4
Bacteremia with Carbapenemase-Producing in Immunocompromised Patients Colonized with These Bacteria.免疫功能低下患者合并产碳青霉烯酶细菌定植者的菌血症
Microb Drug Resist. 2022 May;28(5):593-600. doi: 10.1089/mdr.2021.0253.
5
The Importance of Carbapenemase-Producing Enterobacterales in African Countries: Evolution and Current Burden.产碳青霉烯酶肠杆菌科细菌在非洲国家的重要性:演变与当前负担
Antibiotics (Basel). 2024 Mar 24;13(4):295. doi: 10.3390/antibiotics13040295.
6
Risk Factors and Outcomes of Patients Colonized with KPC and NDM Carbapenemase-Producing Enterobacterales.携带产KPC和NDM碳青霉烯酶肠杆菌科细菌患者的危险因素及转归
Antibiotics (Basel). 2024 May 8;13(5):427. doi: 10.3390/antibiotics13050427.
7
Household Transmission of Carbapenemase-producing Enterobacterales in Ontario, Canada.加拿大安大略省产碳青霉烯酶肠杆菌科的家庭传播。
Clin Infect Dis. 2021 Dec 6;73(11):e4607-e4615. doi: 10.1093/cid/ciaa1295.
8
Prevalence of carbapenem-resistant Enterobacterales with predominance in hospitals from 2018 to 2021 in Nara, Japan.2018年至2021年日本奈良医院耐碳青霉烯类肠杆菌科细菌的流行情况及优势菌。
JAC Antimicrob Resist. 2024 Aug 20;6(4):dlae135. doi: 10.1093/jacamr/dlae135. eCollection 2024 Aug.
9
Carbapenemase-Producing Enterobacteriaceae (CPE) Newborn Colonization in a Portuguese Neonatal Intensive Care Unit (NICU): Epidemiology and Infection Prevention and Control Measures.葡萄牙一家新生儿重症监护病房(NICU)中产碳青霉烯酶肠杆菌科细菌(CPE)的新生儿定植情况:流行病学及感染预防与控制措施
Infect Dis Rep. 2021 May 1;13(2):411-417. doi: 10.3390/idr13020039.
10
A Longitudinal Nine-Year Study of the Molecular Epidemiology of Carbapenemase-Producing Isolated From a Regional Hospital in Taiwan: Predominance of Carbapenemase KPC-2 and OXA-48.台湾某地区医院产碳青霉烯酶分离株的分子流行病学九年纵向研究:碳青霉烯酶KPC-2和OXA-48占主导地位
Front Microbiol. 2022 Mar 11;13:703113. doi: 10.3389/fmicb.2022.703113. eCollection 2022.

引用本文的文献

1
interspecies dissemination of IncM2-type carrying plasmid.携带IncM2型质粒的种间传播
Microbiol Spectr. 2025 Feb 4;13(2):e0039924. doi: 10.1128/spectrum.00399-24. Epub 2024 Dec 17.
2
Investigating a propagation of emerging carbapenemase-producing Enterobacteriaceae in Dutch broiler production pyramid through stochastic simulation.通过随机模拟研究荷兰肉鸡生产金字塔中新兴产碳青霉烯酶肠杆菌科细菌的传播情况。
One Health. 2024 Nov 26;19:100945. doi: 10.1016/j.onehlt.2024.100945. eCollection 2024 Dec.

本文引用的文献

1
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
2
First Report of Bearing IncX3 Plasmid in Clinically Isolated ST11 from Pakistan.巴基斯坦临床分离的ST11中携带IncX3质粒的首次报告。
Microorganisms. 2021 Apr 28;9(5):951. doi: 10.3390/microorganisms9050951.
3
Epidemiologic and Microbiologic Characteristics of Hospitalized Patients Co-colonized With Multiple Species of Carbapenem-Resistant Enterobacteriaceae in the United States.
美国多重碳青霉烯类耐药肠杆菌科细菌共定植住院患者的流行病学和微生物学特征
Open Forum Infect Dis. 2020 Aug 27;7(10):ofaa386. doi: 10.1093/ofid/ofaa386. eCollection 2020 Oct.
4
Identification of loci for capsular polysaccharide (KL) and lipooligosaccharide outer core (OCL) synthesis in genome assemblies using curated reference databases compatible with .利用与. 兼容的经过精心整理的参考数据库,在基因组组装中鉴定荚膜多糖 (KL) 和脂寡糖外核 (OCL) 合成的基因座。
Microb Genom. 2020 Mar;6(3). doi: 10.1099/mgen.0.000339.
5
Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria.革兰氏阴性菌碳青霉烯类耐药的流行病学和诊断学。
Clin Infect Dis. 2019 Nov 13;69(Suppl 7):S521-S528. doi: 10.1093/cid/ciz824.
6
Intestinal co-colonization with different carbapenemase-producing isolates is not a rare event in an OXA-48 endemic area.在OXA-48流行地区,肠道被不同产碳青霉烯酶菌株共定植并非罕见事件。
EClinicalMedicine. 2019 Oct 17;15:72-79. doi: 10.1016/j.eclinm.2019.09.005. eCollection 2019 Oct.
7
Occurrence of Highly Conjugative IncX3 Epidemic Plasmid Carrying in Isolates in Geographically Widespread Areas.在地理分布广泛地区的分离株中携带的高接合性IncX3流行质粒的出现情况。
Front Microbiol. 2018 Sep 20;9:2272. doi: 10.3389/fmicb.2018.02272. eCollection 2018.
8
Antibiotic Resistance.抗生素耐药性。
Cell. 2018 Feb 22;172(5):1136-1136.e1. doi: 10.1016/j.cell.2018.02.018.
9
Israeli National Policy for Carbapenem-Resistant Enterobacteriaceae Screening, Carrier Isolation and Discontinuation of Isolation.以色列碳青霉烯类耐药肠杆菌科筛查、携带者隔离和隔离解除的国家政策。
Infect Control Hosp Epidemiol. 2018 Jan;39(1):85-89. doi: 10.1017/ice.2017.211. Epub 2017 Dec 15.
10
Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study.产碳青霉烯酶肺炎克雷伯菌和大肠埃希菌在欧洲产碳青霉烯酶肠杆菌科的调查(EuSCAPE)中的发生:一项前瞻性、多国研究。
Lancet Infect Dis. 2017 Feb;17(2):153-163. doi: 10.1016/S1473-3099(16)30257-2. Epub 2016 Nov 18.